diquafosol has been researched along with methylthio-adp in 1 studies
Studies (diquafosol) | Trials (diquafosol) | Recent Studies (post-2010) (diquafosol) | Studies (methylthio-adp) | Trials (methylthio-adp) | Recent Studies (post-2010) (methylthio-adp) |
---|---|---|---|---|---|
126 | 38 | 92 | 146 | 2 | 43 |
Protein | Taxonomy | diquafosol (IC50) | methylthio-adp (IC50) |
---|---|---|---|
Cytochrome P450 2C19 | Homo sapiens (human) | 0.04 | |
P2Y purinoceptor 1 | Homo sapiens (human) | 0.1427 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Camden, J; Fischer, B; Weisman, GA; Yelovitch, S | 1 |
1 other study(ies) available for diquafosol and methylthio-adp
Article | Year |
---|---|
Boranophosphate isoster controls P2Y-receptor subtype selectivity and metabolic stability of dinucleoside polyphosphate analogues.
Topics: Animals; Boranes; Calcium; Cell Line, Tumor; Dinucleoside Phosphates; Drug Stability; Humans; Hydrolysis; Models, Molecular; Molecular Conformation; Phosphoric Diester Hydrolases; Purinergic P2Y Receptor Agonists; Pyrophosphatases; Receptors, Purinergic P2Y; Stereoisomerism; Structure-Activity Relationship; Turkey | 2012 |